IL4 and neoplasm: However, other studies have shown that malignant tumor cells genetically engineered to produce IL-4 displayed potent anti-tumor effects in vivo, suggesting the potential use of IL-4 secreting tumor cells as tumor vaccines for treating patients with advanced cancers [25–28].